- New Purchases: CABO, BPMC,
- Added Positions: GLPG,
- Reduced Positions: DERM, XLRN, UMRX,
- Sold Out: MNLO, C,
For the details of Novo A's stock buys and sells, go to https://www.gurufocus.com/guru/novo+a/current-portfolio/portfolio
These are the top 5 holdings of Novo A- Inogen Inc (INGN) - 3,549,320 shares, 52.53% of the total portfolio.
- Glaukos Corp (GKOS) - 605,266 shares, 7.36% of the total portfolio.
- Cable One Inc (CABO) - 45,000 shares, 6.85% of the total portfolio. New Position
- OrthoPediatrics Corp (KIDS) - 654,549 shares, 4.49% of the total portfolio.
- Akebia Therapeutics Inc (AKBA) - 3,100,000 shares, 3.94% of the total portfolio.
Novo A initiated holding in Cable One Inc. The purchase prices were between $803.24 and $985.99, with an estimated average price of $905.69. The stock is now traded at around $1111.43. The impact to a portfolio due to this purchase was 6.85%. The holding were 45,000 shares as of .
New Purchase: Blueprint Medicines Corp (BPMC)Novo A initiated holding in Blueprint Medicines Corp. The purchase prices were between $48.7 and $86.6, with an estimated average price of $73.56. The stock is now traded at around $77.20. The impact to a portfolio due to this purchase was 0.84%. The holding were 67,567 shares as of .
Sold Out: Menlo Therapeutics Inc (MNLO)Novo A sold out a holding in Menlo Therapeutics Inc. The sale prices were between $4.12 and $8.51, with an estimated average price of $6.62.
Sold Out: Citigroup Inc (C)Novo A sold out a holding in Citigroup Inc. The sale prices were between $52.06 and $65.93, with an estimated average price of $61.99.
Here is the complete portfolio of Novo A. Also check out:
1. Novo A's Undervalued Stocks
2. Novo A's Top Growth Companies, and
3. Novo A's High Yield stocks
4. Stocks that Novo A keeps buying
